Trends in BRCA testing and socioeconomic deprivation

Antony P. Martin, Gabriel Pedra, Jennifer Downing , Brendan Collins , Brian Godman, Ana Alfirevic, Munir Pirmohamed , Kathryn Greenhalgh

Research output: Contribution to journalArticle

Abstract

BRCA testing received much publicity following Angelina Jolie’s editorial ‘My Medical Choice’ in May 2013 and updated NICE clinical guidance (CG164) in June 2013. We assessed the effect of these two concurrent events on BRCA testing in one UK catchment area and relate this to socioeconomic deprivation. A database of 1393 patients who received BRCA testing was collated. This included individuals with breast/ovarian cancer, and those unaffected by cancer, where a relative has a ≥10% probability of carrying a BRCA variant which affects function. A segmented regression was conducted to estimate changes in testing. To examine the relative distribution of testing by deprivation, the deprivation status of patients who received testing was examined. Between April 2010-March 2017, testing increased 11-fold and there was an 84% increase (P=0.006) in BRCA1/2 testing in the month following both publications. In the pre-publication period, there was no statistically significant difference in testing between advantaged and disadvantaged areas (OR 1.21 95% CI 0.99-1.48; P=0.06). In the post-publication period helped by a larger sample size, the difference was statistically significant (OR 1.18 95% CI 1.08-1.29; P=0.0002) and of a similar magnitude to the pre-publication period. Testing increased following Jolie’s editorial and NICE guidance update. However further research is needed to examine differences in testing by deprivation group which adjusts for confounders.
LanguageEnglish
Pages1351-1360
Number of pages10
JournalEuropean Journal of Human Genetics
Volume27
Issue number9
DOIs
Publication statusPublished - 3 May 2019

Fingerprint

Publications
Vulnerable Populations
Sample Size
Ovarian Neoplasms
Databases
Breast Neoplasms
Research
Neoplasms

Keywords

  • hereditary breast ovarian cancer
  • equity
  • uptake

Cite this

Martin, A. P., Pedra, G., Downing , J., Collins , B., Godman, B., Alfirevic, A., ... Greenhalgh, K. (2019). Trends in BRCA testing and socioeconomic deprivation. European Journal of Human Genetics, 27(9), 1351-1360. https://doi.org/10.1038/s41431-019-0424-3
Martin, Antony P. ; Pedra, Gabriel ; Downing , Jennifer ; Collins , Brendan ; Godman, Brian ; Alfirevic, Ana ; Pirmohamed , Munir ; Greenhalgh, Kathryn . / Trends in BRCA testing and socioeconomic deprivation. In: European Journal of Human Genetics. 2019 ; Vol. 27, No. 9. pp. 1351-1360.
@article{24c9189330994113b06a6d86e8f8cfe2,
title = "Trends in BRCA testing and socioeconomic deprivation",
abstract = "BRCA testing received much publicity following Angelina Jolie’s editorial ‘My Medical Choice’ in May 2013 and updated NICE clinical guidance (CG164) in June 2013. We assessed the effect of these two concurrent events on BRCA testing in one UK catchment area and relate this to socioeconomic deprivation. A database of 1393 patients who received BRCA testing was collated. This included individuals with breast/ovarian cancer, and those unaffected by cancer, where a relative has a ≥10{\%} probability of carrying a BRCA variant which affects function. A segmented regression was conducted to estimate changes in testing. To examine the relative distribution of testing by deprivation, the deprivation status of patients who received testing was examined. Between April 2010-March 2017, testing increased 11-fold and there was an 84{\%} increase (P=0.006) in BRCA1/2 testing in the month following both publications. In the pre-publication period, there was no statistically significant difference in testing between advantaged and disadvantaged areas (OR 1.21 95{\%} CI 0.99-1.48; P=0.06). In the post-publication period helped by a larger sample size, the difference was statistically significant (OR 1.18 95{\%} CI 1.08-1.29; P=0.0002) and of a similar magnitude to the pre-publication period. Testing increased following Jolie’s editorial and NICE guidance update. However further research is needed to examine differences in testing by deprivation group which adjusts for confounders.",
keywords = "hereditary breast ovarian cancer, equity, uptake",
author = "Martin, {Antony P.} and Gabriel Pedra and Jennifer Downing and Brendan Collins and Brian Godman and Ana Alfirevic and Munir Pirmohamed and Kathryn Greenhalgh",
year = "2019",
month = "5",
day = "3",
doi = "10.1038/s41431-019-0424-3",
language = "English",
volume = "27",
pages = "1351--1360",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
number = "9",

}

Martin, AP, Pedra, G, Downing , J, Collins , B, Godman, B, Alfirevic, A, Pirmohamed , M & Greenhalgh, K 2019, 'Trends in BRCA testing and socioeconomic deprivation' European Journal of Human Genetics, vol. 27, no. 9, pp. 1351-1360. https://doi.org/10.1038/s41431-019-0424-3

Trends in BRCA testing and socioeconomic deprivation. / Martin, Antony P.; Pedra, Gabriel ; Downing , Jennifer ; Collins , Brendan ; Godman, Brian; Alfirevic, Ana ; Pirmohamed , Munir ; Greenhalgh, Kathryn .

In: European Journal of Human Genetics, Vol. 27, No. 9, 03.05.2019, p. 1351-1360.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trends in BRCA testing and socioeconomic deprivation

AU - Martin, Antony P.

AU - Pedra, Gabriel

AU - Downing , Jennifer

AU - Collins , Brendan

AU - Godman, Brian

AU - Alfirevic, Ana

AU - Pirmohamed , Munir

AU - Greenhalgh, Kathryn

PY - 2019/5/3

Y1 - 2019/5/3

N2 - BRCA testing received much publicity following Angelina Jolie’s editorial ‘My Medical Choice’ in May 2013 and updated NICE clinical guidance (CG164) in June 2013. We assessed the effect of these two concurrent events on BRCA testing in one UK catchment area and relate this to socioeconomic deprivation. A database of 1393 patients who received BRCA testing was collated. This included individuals with breast/ovarian cancer, and those unaffected by cancer, where a relative has a ≥10% probability of carrying a BRCA variant which affects function. A segmented regression was conducted to estimate changes in testing. To examine the relative distribution of testing by deprivation, the deprivation status of patients who received testing was examined. Between April 2010-March 2017, testing increased 11-fold and there was an 84% increase (P=0.006) in BRCA1/2 testing in the month following both publications. In the pre-publication period, there was no statistically significant difference in testing between advantaged and disadvantaged areas (OR 1.21 95% CI 0.99-1.48; P=0.06). In the post-publication period helped by a larger sample size, the difference was statistically significant (OR 1.18 95% CI 1.08-1.29; P=0.0002) and of a similar magnitude to the pre-publication period. Testing increased following Jolie’s editorial and NICE guidance update. However further research is needed to examine differences in testing by deprivation group which adjusts for confounders.

AB - BRCA testing received much publicity following Angelina Jolie’s editorial ‘My Medical Choice’ in May 2013 and updated NICE clinical guidance (CG164) in June 2013. We assessed the effect of these two concurrent events on BRCA testing in one UK catchment area and relate this to socioeconomic deprivation. A database of 1393 patients who received BRCA testing was collated. This included individuals with breast/ovarian cancer, and those unaffected by cancer, where a relative has a ≥10% probability of carrying a BRCA variant which affects function. A segmented regression was conducted to estimate changes in testing. To examine the relative distribution of testing by deprivation, the deprivation status of patients who received testing was examined. Between April 2010-March 2017, testing increased 11-fold and there was an 84% increase (P=0.006) in BRCA1/2 testing in the month following both publications. In the pre-publication period, there was no statistically significant difference in testing between advantaged and disadvantaged areas (OR 1.21 95% CI 0.99-1.48; P=0.06). In the post-publication period helped by a larger sample size, the difference was statistically significant (OR 1.18 95% CI 1.08-1.29; P=0.0002) and of a similar magnitude to the pre-publication period. Testing increased following Jolie’s editorial and NICE guidance update. However further research is needed to examine differences in testing by deprivation group which adjusts for confounders.

KW - hereditary breast ovarian cancer

KW - equity

KW - uptake

UR - https://www.nature.com/ejhg/volumes

U2 - 10.1038/s41431-019-0424-3

DO - 10.1038/s41431-019-0424-3

M3 - Article

VL - 27

SP - 1351

EP - 1360

JO - European Journal of Human Genetics

T2 - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 9

ER -

Martin AP, Pedra G, Downing J, Collins B, Godman B, Alfirevic A et al. Trends in BRCA testing and socioeconomic deprivation. European Journal of Human Genetics. 2019 May 3;27(9):1351-1360. https://doi.org/10.1038/s41431-019-0424-3